SARS-CoV-2-IN-110

MedChem Express

SARS-CoV-2-IN-110

5

SARS-CoV-2-IN-110 (compound Bb1) is a SARS-CoV-2 inhibitor. SARS-CoV-2-IN-110 exhibits antiviral efficacy against SARS-CoV-2 with an EC 50 of 1.10 microM and significantly lower toxicity compared to Lapatinib (HY-50898). SARS-CoV-2-IN-110 inhibits SARS-CoV-2 with a CC 50 of > 100 microM, with a selectivity index (SI) of >91 [1] .

12352200